BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29913211)

  • 1. Nrf2: Molecular and epigenetic regulation during aging.
    Silva-Palacios A; Ostolga-Chavarría M; Zazueta C; Königsberg M
    Ageing Res Rev; 2018 Nov; 47():31-40. PubMed ID: 29913211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging.
    Yu C; Xiao JH
    Oxid Med Cell Longev; 2021; 2021():6635460. PubMed ID: 34012501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
    Fão L; Mota SI; Rego AC
    Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
    Sharma V; Kaur A; Singh TG
    Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3β Axis.
    Anzovino A; Chiang S; Brown BE; Hawkins CL; Richardson DR; Huang ML
    Am J Pathol; 2017 Dec; 187(12):2858-2875. PubMed ID: 28935570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of Keap1-Nrf2 signaling.
    Guo Y; Yu S; Zhang C; Kong AN
    Free Radic Biol Med; 2015 Nov; 88(Pt B):337-349. PubMed ID: 26117320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes of Nrf2 and phosphorylated GSK-3β in a mouse model of accelerated aging (SAMP8).
    Tomobe K; Shinozuka T; Kuroiwa M; Nomura Y
    Arch Gerontol Geriatr; 2012; 54(2):e1-7. PubMed ID: 21784539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
    Rojo AI; Medina-Campos ON; Rada P; Zúñiga-Toalá A; López-Gazcón A; Espada S; Pedraza-Chaverri J; Cuadrado A
    Free Radic Biol Med; 2012 Jan; 52(2):473-87. PubMed ID: 22142471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion.
    Chen X; Liu Y; Zhu J; Lei S; Dong Y; Li L; Jiang B; Tan L; Wu J; Yu S; Zhao Y
    Sci Rep; 2016 Feb; 6():20196. PubMed ID: 26838164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS; Tseng YT; Hsu YY; Lo YC
    Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3β Inactivation.
    Xing HY; Cai YQ; Wang XF; Wang LL; Li P; Wang GY; Chen JH
    PLoS One; 2015; 10(12):e0145183. PubMed ID: 26674355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice.
    Yagishita Y; Fukutomi T; Sugawara A; Kawamura H; Takahashi T; Pi J; Uruno A; Yamamoto M
    Diabetes; 2014 Feb; 63(2):605-18. PubMed ID: 24186865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
    Giudice A; Arra C; Turco MC
    Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.
    Sun Z; Zhang S; Chan JY; Zhang DD
    Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
    O'Connell MA; Hayes JD
    Biochem Soc Trans; 2015 Aug; 43(4):687-9. PubMed ID: 26551713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3β.
    Song JS; Kim EK; Choi YW; Oh WK; Kim YM
    Toxicol Appl Pharmacol; 2016 Sep; 307():138-149. PubMed ID: 27511913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
    Yang SP; Yang XZ; Cao GP
    Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human age‑related cataracts: epigenetic suppression of the nuclear factor erythroid 2‑related factor 2‑mediated antioxidant system.
    Gao Y; Yan Y; Huang T
    Mol Med Rep; 2015 Feb; 11(2):1442-7. PubMed ID: 25370996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.